Reinhard J. Ambros has served as the global head of the Novartis Venture Fund from 2005-2017 and built one of the largest ~$1bn and most active corporate Biotechnology Venture Funds globally. He has led more than eighty new investments and was involved in over fifty exits, IPOs & M&A. As the fund manager, he built a team of respected investment managers in Europe and the US and established a network with key finance syndicate partners and pharma organizations. Reinhard also serves on the board of several other private and public biotechnology companies in Europe and the US.
In his former position, he was the head of Group Strategic Planning for Novartis AG and led business development and licensing in the cardiovascular and metabolic disease area for Novartis Pharma AG. Earlier in his career, he led international projects for pharmaceutical product development in various therapeutic areas for Novartis Pharma AG and Hoffmann-La Roche.